First-Line Gemcitabine Plus Cisplatin in Nonsmall Cell Lung Cancer Patients

Figure 4

Kaplan-Meier survival analyses for RRM1 (a), ERCC1 (b), and BRCA1 (c) in Chinese patients with NSCLC based on median values of gene expression in overall population.

(a)

(b)

(c)